"The need for reintervention or additional procedures is the Achilles heel of endovascular treatments," said Ali Azizzadeh, MD. In this episode of "Pioneers in Medicine," the Director and Chief of Vascular Surgery discusses the transition from open to endovascular techniques, quality control methods for devices and grafts and how this field will look after new developments have been made in vascular surgery.
Learn more about Dr. Ali Azizzadeh: [ Ссылка ]
Learn more about Dr. Bruce Gewertz: [ Ссылка ]
For Healthcare Professionals: To claim CME credit for this activity, please click the link to be redirected to the Cedars-Sinai CME Portal at [ Ссылка ]
Connect with us:
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars- Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow’s health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.
